165 related articles for article (PubMed ID: 35066377)
21. Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination.
Zhou YX; Pannu R; Le TQ; Armstrong RC
Neurobiol Dis; 2012 Jan; 45(1):196-205. PubMed ID: 21854849
[TBL] [Abstract][Full Text] [Related]
22. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression.
Kotter MR; Zhao C; van Rooijen N; Franklin RJ
Neurobiol Dis; 2005 Feb; 18(1):166-75. PubMed ID: 15649707
[TBL] [Abstract][Full Text] [Related]
23. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
[TBL] [Abstract][Full Text] [Related]
24. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
25. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.
Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG
Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256
[TBL] [Abstract][Full Text] [Related]
26. Statin therapy inhibits remyelination in the central nervous system.
Miron VE; Zehntner SP; Kuhlmann T; Ludwin SK; Owens T; Kennedy TE; Bedell BJ; Antel JP
Am J Pathol; 2009 May; 174(5):1880-90. PubMed ID: 19349355
[TBL] [Abstract][Full Text] [Related]
27. Tropomyosin Receptor Kinase B Expressed in Oligodendrocyte Lineage Cells Functions to Promote Myelin Following a Demyelinating Lesion.
Huang Y; Song YJ; Isaac M; Miretzky S; Patel A; Geoffrey McAuliffe W; Dreyfus CF
ASN Neuro; 2020; 12():1759091420957464. PubMed ID: 32927995
[TBL] [Abstract][Full Text] [Related]
28. Solifenacin promotes remyelination in cuprizone mouse model by inhibiting the Wnt/β-catenin signaling pathway.
Xu X; Song X; Chen F; Yan W; Meng Q; Liu J; Yao R; Liu Y; Dong F
J Chem Neuroanat; 2024 Mar; 136():102375. PubMed ID: 38123002
[TBL] [Abstract][Full Text] [Related]
29. miR-219 attenuates demyelination in cuprizone-induced demyelinated mice by regulating monocarboxylate transporter 1.
Liu S; Ren C; Qu X; Wu X; Dong F; Chand YK; Fan H; Yao R; Geng D
Eur J Neurosci; 2017 Jan; 45(2):249-259. PubMed ID: 27873367
[TBL] [Abstract][Full Text] [Related]
30. Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination.
Tsiperson V; Huang Y; Bagayogo I; Song Y; VonDran MW; DiCicco-Bloom E; Dreyfus CF
ASN Neuro; 2015; 7(1):. PubMed ID: 25586993
[TBL] [Abstract][Full Text] [Related]
31. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
El-Etr M; Rame M; Boucher C; Ghoumari AM; Kumar N; Liere P; Pianos A; Schumacher M; Sitruk-Ware R
Glia; 2015 Jan; 63(1):104-17. PubMed ID: 25092805
[TBL] [Abstract][Full Text] [Related]
32. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U
CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941
[TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
Liu L; Du X; Yang Q; Li M; Ran Q; Liu Q; Yang L; Sun L; Guo Y; Li Y; Chen Y; Zhu X; Li Q
Phytomedicine; 2022 Nov; 106():154309. PubMed ID: 35994846
[TBL] [Abstract][Full Text] [Related]
34. Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor.
Sherafat A; Pfeiffer F; Reiss AM; Wood WM; Nishiyama A
Nat Commun; 2021 Apr; 12(1):2265. PubMed ID: 33859199
[TBL] [Abstract][Full Text] [Related]
35. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
[TBL] [Abstract][Full Text] [Related]
36. Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells.
Giera S; Luo R; Ying Y; Ackerman SD; Jeong SJ; Stoveken HM; Folts CJ; Welsh CA; Tall GG; Stevens B; Monk KR; Piao X
Elife; 2018 May; 7():. PubMed ID: 29809138
[TBL] [Abstract][Full Text] [Related]
37. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
Petković F; Campbell IL; Gonzalez B; Castellano B
Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761
[TBL] [Abstract][Full Text] [Related]
38. K+ channel blockade impairs remyelination in the cuprizone model.
Bacia A; Wollmann R; Soliven B
Glia; 2004 Nov; 48(2):156-65. PubMed ID: 15378653
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
[TBL] [Abstract][Full Text] [Related]
40. NEP1-40 alleviates behavioral phenotypes and promote oligodendrocyte progenitor cell differentiation in the hippocampus of cuprizone-induced demyelination mouse model.
Liu Q; Lv HW; Yang S; He YQ; Ma QR; Liu J
Neurosci Lett; 2020 Apr; 725():134872. PubMed ID: 32112820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
